Explore more by category
Period
Filter by
recent search
Showing: 1 – 5 of 178 stories
27 November 2025 – 0 mins read
This is My PBC
This is My PBC is a disease awareness initiative developed and funded by Ipsen, that seeks to raise awareness of the need for people living with PBC to know more about their disease and understand that everyone’s experience is different – and valid. By taking a personalized approach to your PBC management, you can empower yourself with the knowledge to have meaningful conversations with your healthcare professional, and play a more active role in your PBC management and care. You may be unique, but you are not alone.
25 November 2025 – 0 mins read
Meet Jo, living with PBC
Jo’s journey to diagnosis began about 10 years ago, when she contacted her GP feeling tired and run down, but it wasn’t until 4 years ago following some routine blood tests and a liver biopsy, that she received a diagnosis. Support groups, like the PBC Foundation, have been a gamechanger for Jo, providing support, education and a like-minded community.
25 November 2025 – 0 mins read
Meet Wendy, living with PBC
Wendy has been living with PBC for over 13 years, and it took 5 years of GP and specialist appointments to receive her diagnosis. Her advice to other people living with PBC is to go to your doctor prepared to ask lots of questions, manage your condition as well as you can and be kind to yourself.
25 November 2025 – 0 mins read
Meet Gill, living with PBC
Gill is a devoted mother and grandmother who loves spending time with her grandchildren and gardening. She also has a real passion for her volunteering work. She has lived for over 20 years with PBC.
19 November 2025 – 2 mins read
Built to endure: Prince Korah on relentless pursuit of robust drug product development.
Robustness is not a box to check—it’s the foundation of every decision. As a Senior Director in the Pharmaceutical Development function in Ipsen’s drug product development team, Prince Korah focuses on driving the pharmaceutical development strategy by overseeing the end-to-end life cycle of drug products with his team.




